Pharmaceutical and Immunological Evaluation of Cholera Toxin A1 Subunit as an Adjuvant of Hepatitis B Vaccine Microneedles.

Jong-Chan KimJung-Ah ChoiHayan ParkEunji YangShinyoung NohJi-Seok KimMoon-Jin KimManki SongJung-Hwan Park

Published in: Pharmaceutical research (2023)

CTA1 is an adjuvant that satisfies both the delivery efficiency and the immunological characteristics required for vaccine microneedles. CTA1 will be used as a potential adjuvant through vaccine microneedles.

Keyphrases

early stage
escherichia coli
protein kinase